Login / Signup

Patient perspectives of lithium and quetiapine augmentation treatment in treatment-resistant depression: A qualitative assessment.

Lucas McKeownRachael Wallis TaylorElana DayRupal ShahLindsey MarwoodHelena TeeJess Kerr-GaffneyEmanuella OpreaJohn R GeddesR Hamish McAllister-WilliamsAllan H YoungAnthony J Cleare
Published in: Journal of psychopharmacology (Oxford, England) (2022)
Patient accounts suggested treatment augmentation with lithium or quetiapine was acceptable and helpful for most patients. However, anticipation and experiences of adverse side effects may prevent some patients from benefitting from these treatments.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • prognostic factors
  • emergency department
  • patient reported outcomes
  • smoking cessation